Insight into Exchange Traded Funds by Country

Premium Member
Website Login
Lost password?

Home Page
Why ETFs
Why Global
Why Chartwell
ETF Library
Contact Us
Important Disclaimers

Premium Website Membership >

Click here for details.

Now 50% Off
Just $125/quarter
Purchase Now >

30 Day Money Back Guarantee

Click Here for your
FREE Copy of...

ETF Press Sources

Forbes.com

CNBC

Barron's

ETF Country Insight

Article Overview

Country Insight is for investors looking for a fact filled and descriptive picture of a country's people, economy, politics and investment potential.

Previous Posts

Forbes Stock of the Week: "Sipping a Singapore Sling"
Sell China ETF, Buy Southeast Asia
Follow Condi to Indonesia
Brazil's Stronger Balance Sheet
Getting the Jump on Air Force One
Japan Hits a Speed Bump
Canada Plays China Card
Germany's Upside Potential

Thursday, June 22nd, 2006

Forbes Stock of the Week: "Sipping a Singapore Sling"

Forbes.com Stock Of The Week
Sipping A Singapore Sling

John Dobosz, 06.21.06, 3:35 PM ET

Carl Delfeld, editor of Chartwell Advisor, recommends buying into the iShares MSCI Singapore Index (amex: EWS), the exchange-traded fund representing stocks traded on the Singapore Stock Exchange.

Delfeld calls the Singapore iShares ‰¥þthe highest-quality Asian country ETF.‰¥ÿ The fund‰¥ús holdings are concentrated in the banking industry, with double-digit percentages invested in names such as DBS Group, Oversea-Chinese Banking and United Overseas Bank.

At around $8.40, the Singapore index is down about 14% from its high of $9.75 on May 8. The StraitsTimes index now trades at 14 times earnings. By contrast, before the Asian crisis of 1997, it was at 27 times earnings.

A strong factor underpinning future growth, says Delfeld, is Singapore’s effort to become a global hub of biotechnology research and development, and he is encouraged by the government’s support for helping the industry to blossom.

“From 2000 to 2005, the government‰¥ús financial funding for life sciences R&D was just under $2 billion, and over the next five years the Science & Technology 2010 Plan will commit $5 billion toward economic-driven R&D,” he says.

“Singapore is searching the globe for talent and offers big bucks for scientists to come and conduct research,” he adds, noting that big pharmaceutical companies, such as Merck and Eli Lilly, are already active in Singapore. “Corporate partnerships such as the Singapore-based Novartis Institute for Tropical Diseases are also important for establishing credibility, using resources and attracting talent.”

Even after the correction in the past six weeks, the Singapore index is still up more than 5% for the year, compared to the 4% gain for the iShares MSCI EAFE Index (EFA). The expense ratio is 0.58%.

©2008 ChartwellETF.com
Colorado Springs, CO
Toll Free - 877.202.4939
719.264.1503
info@ChartwellETF.com

ETFpickoftheweek.com
Receive Carl's ETF pick each Friday.

Just $40/month

Click Here for details

Carl Delfeld
Investment Advisor

  • ETF Specialist with Union Bank of Switzerland
  • U.S. Representative,
    Asian Development Bank
  • Forbes Asia Columnist
  • Stockbroker in Tokyo, Hong Kong & Sydney
  • U.S. Treasury consultant
  • Graduate of Fletcher School of Law & Diplomacy
  • Fellow at Keio and Sophia University, Tokyo, Japan

Read what Members
are saying about ChartwellETF.com and Carl Delfeld